Kathleen P. Pratt

Ph.D.

Department of Primary Appointment:
School of Medicine
Medicine
Title
Professor and Vice Chair for Research
Location: Uniformed Services University of the Health Sciences, Bethesda, MD
Research Interests:
Hematologic and immune disorders
Immune tolerance (see biography for more)
Office Phone

Education

1976: B.A. Liberal Arts, The Evergreen State College, Olympia, WA
1984: B.S. Mathematical Sciences, University of Washington, Seattle, WA
1992: Ph.D. Biophysical Chemistry, Cornell University, Ithaca, NY

Biography

Dr. Pratt has studied the structure, function, and immunogenicity of blood coagulation factor VIII (FVIII) for over 20 years. Her studies of alloimmune responses to FVIII encompass structure/function studies, investigations of cellular immune responses to FVIII, mapping of T-cell and B-cell epitopes, RNASeq/transcriptomics and TCR repertoire analysis of PBMCs and specific lymphocyte populations, and characterization of T-cell clones and polyclonal lines from patients as well as hemophilic mice.

Recent work has included analysis of the national “My Life Our Future” database, which revealed that African American and Hispanic patients have a higher risk of developing neutralizing anti-FVIII antibodies; we also identified both risk-associated and protective HLA haplotypes and are currently conducting a GWAS analysis of whole genome sequences from these participants.

Additional information about her lab's current projects and grants can be found here: https://medschool.usuhs.edu/med/research/hematology-lab

Career Highlights: Positions, Projects, Deployments, Awards and Additional Publications

2019: Professor and 2020 Vice Chair for Research, F. Edward Hébert School of Medicine, Department of Medicine, Uniformed Services University of the Health Sciences (USUHS), Bethesda, MD

2014-2019:Associate Professor, F. Edward Hébert School of Medicine, Department of Medicine, Uniformed Services University of the Health Sciences (USUHS), Bethesda, MD

2013-2014: Assistant Professor, F. Edward Hébert School of Medicine, Department of Medicine, Uniformed Services University of the Health Sciences (USUHS), Bethesda, MD

2008-2013: Assistant Research Professor, University of Washington School of Medicine, Division of Hematology, Seattle, WA

2006-2013: Assistant Member, Puget Sound Blood Center Research Institute, Seattle, WA

2003-2006: Research Scientist, Puget Sound Blood Center, Seattle, WA

1999-2003: Staff Scientist, Hutchinson Cancer Research Center, Seattle, WA

2008 “Henri Chaigneau” Prize of the Association Française des Hémophiles

2019 Dean's Impact Award, F. Edward Hébert School of Medicine, Department of Medicine, Uniformed Services University of the Health Sciences

2021 National Hemophilia Foundation "Hemophilia Researcher of the Year" award

Representative Bibliography

Roberts TR, Villalobos PA, Bigon EB, Haden GA, Kill HJ, BA, Pratt KP, Batchinsky AI. von Willebrand Factor Dynamics in Trauma Managed with Extracorporeal Life Support. Journal of Thrombosis and Hemostasis 2026 May; 24(5)1677-89. doi: 10.1016/j.jtha.2026.01.024. PMID 41692097

Contente S, Ahmed AE, Konkle BA, Johnsen JM, Frank A, Pratt KP. HLA alleles associated with inhibitor development in severe hemophilia A: Analysis of the “My Life, Our Future” Hemophilia A cohort. J Thromb Haemost. 2026 Feb;24(2):443-457. doi: 10.1016/j.jtha.2025.08.040. PMID: 41644240.

Vir P, Karim A-F, Gunasekera D, Stering A, Lieuw K, Meeks S, Pratt KP. Rare CD4 T cell responses reveal FVIII immunogenicity in non-hemophilic individuals. J Thromb Haemost. 2025 Dec 12:S1538-7836(25)00889-X. doi: 10.1016/j.jtha.2025.11.013. Online ahead of print. PMID: 41391568

Vir P, Gunasekera D, Dorjbal B, Agrawal A, McDaniel D, Merricks EM, Ragni MV, Leissinger C, Stering AI, Lieuw K, Nichols TC, Pratt KP. Lack of FVIII detection in humans and dogs with an intron-22 inversion mutation challenges hypothesis regarding inhibitor risk. J Thromb Haemost 2024 Sep 2:S1538-7836(24)00493-8. doi: 10.1016/j.jtha.2024.08.007. PMID 39233012

Karim AF, Soltis AR, Sukumar G, Konigs C, Ewing N, Dalgard CL, Wilkerson MD, Pratt KP. Hemophilia A inhibitor subjects show unique PBMC gene expression profiles that include up- regulated immune modulators. Frontiers in Immunology 2020, June 12. Doi: 10.3389/fimmu.2020.01219. PMCID: PMC7303277

Lacroix-Desmazes S, Voorberg J, Lilicrap D, Scott DW, Pratt KP. Tolerating Factor VIII: Recent Progress. Frontiers in Immunology 2020 Jan 10;10:2991. doi: 10.3389/fimmu.2019.02991. PMID: 31998296.